Literature DB >> 27871513

Disagreement between fourth generation FloTrac and LiDCOrapid measurements of cardiac output and stroke volume variation during laparoscopic colectomy.

Masato Nakasuji1, Aki Okutani2, Taeko Miyata3, Norie Imanaka4, Masuji Tanaka5, Kae Nakasuji6, Miwako Nagai7.   

Abstract

STUDY
OBJECTIVE: To determine the agreement between cardiac output (CO) and stroke volume variation (SVV) measured simultaneously by the fourth generation FloTrac/Vigileo system and LiDCOrapid system during pneumoperitoneum in patients undergoing laparoscopic colectomy.
DESIGN: Retrospective observational study. SETTINGS: Operating room in a general hospital. PATIENTS: Ten patients (American Society of Anesthesiologist 1 or 2) without preoperative anemia.
INTERVENTIONS: A 22-gauge catheter was inserted in the radial artery after induction of anesthesia. The arterial line was split to monitor CO and SVV simultaneously with the LiDCOrapid and fourth generation FloTrac/Vigileo systems. All data were downloaded from each system after surgery and simultaneous paired COFloTrac, COLiDCO and SVVFloTrac, SVVLiDCO values estimated every 1 minute during the pneumoperitoneum were analyzed. MEASUREMENTS: To assess the agreement after carbon dioxide insufflation, a scatter 4-quadrant plot was generated using paired ΔCO values (changes in COFloTrac and COLiDCO just before pneumoperitoneum and 3 minutes after the induction of pneumoperitoneum). For data in which SVVFloTrac was >9% but <16% and cardiac index measured by FloTrac/Vigileo was <2.5 L/min per m2 during stable pneumoperitoneum (the period from 5 minutes after Trendelenburg position until discontinuation of pneumoperitoneum), simultaneously measured paired SVVFloTrac and SVVLiDCO were plotted every 1 minute using the Bland-Altman method. MAIN
RESULTS: A concordance ratio for changes in CO after the induction of pneumoperitoneum was 83% in 4-quadrant plot. During stable pneumoperitoneum, 702 paired SVVFloTrac and SVVLiDCO matched the criteria. These data sets were plotted by the Bland-Altman method and the bias and 95% limit of agreement of SVV were 2.01 and -2.63% to 6.65%, respectively, with 38% percentage error. The regression equation was SVVLiDCO = 0.98 × SVVFloTrac- 1.73 with Pearson correlation coefficient of 0.55.
CONCLUSIONS: Our study showed disagreement between the 2 methods and the hemodynamic parameters measured by one of the two devices should be interpreted with caution before therapeutic interventions.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FloTrac/Vigileo; Laparoscopic colectomy; LiDCO; Pneumoperitoneum

Mesh:

Substances:

Year:  2016        PMID: 27871513     DOI: 10.1016/j.jclinane.2016.07.036

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


  4 in total

Review 1.  Accuracy of non-invasive and minimally invasive hemodynamic monitoring: where do we stand?

Authors:  Issa Pour-Ghaz; Theodore Manolukas; Nathalie Foray; Joel Raja; Aranyak Rawal; Uzoma N Ibebuogu; Rami N Khouzam
Journal:  Ann Transl Med       Date:  2019-09

2.  Evaluation of the use of the fourth version FloTrac system in cardiac output measurement before and after cardiopulmonary bypass.

Authors:  Sheng-Yi Lin; An-Hsun Chou; Yung-Fong Tsai; Su-Wei Chang; Min-Wen Yang; Pei-Chi Ting; Chun-Yu Chen
Journal:  J Clin Monit Comput       Date:  2017-10-16       Impact factor: 2.502

3.  Effect of liberal versus restrictive fluid therapy on intraoperative lactate levels in robot- assisted colorectal surgery.

Authors:  Lakshmi Kumar; Kalyan Kumar; Sai Sandhya; Deepa M Koshy; Kruthika P Ramamurthi; Sunil Rajan
Journal:  Indian J Anaesth       Date:  2020-07-01

4.  Effects of continuous infusion of phenylephrine vs. norepinephrine on parturients and fetuses under LiDCOrapid monitoring: a randomized, double-blind, placebo-controlled study.

Authors:  Kunpeng Feng; Xiaohua Wang; Xuexin Feng; Jinfeng Zhang; Wei Xiao; Fengying Wang; Qi Zhou; Tianlong Wang
Journal:  BMC Anesthesiol       Date:  2020-09-07       Impact factor: 2.217

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.